Reata Pharmaceuticals Inc. — Sponsor Intelligence | 1 EU Trials

Filter these 1 trials by condition, phase, country and more.

1 Registered trials

0 Recruiting

2 Completed trials

2 Countries active

1 Unique IMPs

100% Results reported

Phase II

Oversight events:

2 unexpected events across 2 trials

100%

2 of 2 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

Top indications

1 total

Showing 1–1 of 1 trials